HCM
NEOS

Hodges Capital Management’s Neos Therapeutics, Inc NEOS Stock Holding History

Hodges Capital Management’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-150,000
Closed -$1.62M – 294
2016
Q1 		$1.62M Buy
150,000
+100,000
+200% +$1.05M 0.07% 140
2015
Q4 		$716K Buy
+50,000
New +$754K 0.03% 195

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Hodges Capital Management's NEOS Position: Q2 2016 in Review

Hodges Capital Management sold out of Neos Therapeutics, Inc (NEOS) in Q2 2016, closing a stake of 150,000 shares — an estimated $1.62M sold.

Hodges Capital Management first reported a position in NEOS in Q4 2015 and held it in 2 quarters. The position peaked at $1.62M in Q1 2016. 46 funds tracked by Wall St. Rank hold NEOS as of Q2 2016.

  • Hodges Capital Management reported no remaining Neos Therapeutics, Inc position as of Q2 2016 after selling out during the quarter.
  • Hodges Capital Management sold 150,000 Neos Therapeutics, Inc shares in Q2 2016, an estimated $1.62M.
  • Hodges Capital Management first reported a position in Neos Therapeutics, Inc in Q4 2015 and held it in 2 quarters.
  • Hodges Capital Management's Neos Therapeutics, Inc position peaked at $1.62M in Q1 2016.
  • 46 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2016.

Based on Hodges Capital Management's 13F filing for Q2 2016, filed 11 Aug 2016.